1. Home
  2. VCEL vs MDBH Comparison

VCEL vs MDBH Comparison

Compare VCEL & MDBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • MDBH
  • Stock Information
  • Founded
  • VCEL 1989
  • MDBH 1997
  • Country
  • VCEL United States
  • MDBH United States
  • Employees
  • VCEL N/A
  • MDBH N/A
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • MDBH
  • Sector
  • VCEL Health Care
  • MDBH
  • Exchange
  • VCEL Nasdaq
  • MDBH Nasdaq
  • Market Cap
  • VCEL 2.1B
  • MDBH 42.1M
  • IPO Year
  • VCEL 1997
  • MDBH 2023
  • Fundamental
  • Price
  • VCEL $42.55
  • MDBH $4.48
  • Analyst Decision
  • VCEL Strong Buy
  • MDBH
  • Analyst Count
  • VCEL 8
  • MDBH 0
  • Target Price
  • VCEL $62.00
  • MDBH N/A
  • AVG Volume (30 Days)
  • VCEL 439.0K
  • MDBH 5.3K
  • Earning Date
  • VCEL 07-31-2025
  • MDBH 08-12-2025
  • Dividend Yield
  • VCEL N/A
  • MDBH N/A
  • EPS Growth
  • VCEL 521.85
  • MDBH N/A
  • EPS
  • VCEL 0.05
  • MDBH 0.84
  • Revenue
  • VCEL $238,541,000.00
  • MDBH $3,574,131.00
  • Revenue This Year
  • VCEL $23.03
  • MDBH N/A
  • Revenue Next Year
  • VCEL $24.52
  • MDBH N/A
  • P/E Ratio
  • VCEL $724.21
  • MDBH $4.93
  • Revenue Growth
  • VCEL 14.80
  • MDBH N/A
  • 52 Week Low
  • VCEL $37.39
  • MDBH $3.61
  • 52 Week High
  • VCEL $63.00
  • MDBH $12.00
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 51.57
  • MDBH 58.06
  • Support Level
  • VCEL $40.53
  • MDBH $3.72
  • Resistance Level
  • VCEL $43.51
  • MDBH $4.90
  • Average True Range (ATR)
  • VCEL 1.77
  • MDBH 0.21
  • MACD
  • VCEL -0.08
  • MDBH 0.11
  • Stochastic Oscillator
  • VCEL 42.62
  • MDBH 76.26

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About MDBH MDB Capital Holdings LLC common

MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.

Share on Social Networks: